SPONSOR
Fernando Maciel Barbosa
Total Trials
1
Recruiting
1
Phases
Phase 1
Fernando Maciel Barbosa is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Renal Cell Carcinoma, Advanced Melanoma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fernando Maciel Barbosa
How many clinical trials has Fernando Maciel Barbosa sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Fernando Maciel Barbosa, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Renal Cell Carcinoma, Advanced Melanoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fernando Maciel Barbosa research focus on?
Fernando Maciel Barbosa clinical trials span Advanced Renal Cell Carcinoma, Advanced Melanoma. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fernando Maciel Barbosa clinical trial?
To participate in a Fernando Maciel Barbosa trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fernando Maciel Barbosa trials with current recruitment status updated daily.
Clinical Trials by Fernando Maciel Barbosa
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology